BioLight Life Sciences Ltd (BOLT) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.137x

Based on the latest financial reports, BioLight Life Sciences Ltd (BOLT) has a cash flow conversion efficiency ratio of -0.137x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-5.49 Million ≈ $-14.72K USD) by net assets (ILA40.17 Million ≈ $107.70K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see BioLight Life Sciences Ltd (BOLT) market capitalisation for the company's overall valuation and market capitalisation.

BioLight Life Sciences Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how BioLight Life Sciences Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View BOLT stock price and chart for real-time trading data and today's change.

BioLight Life Sciences Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BioLight Life Sciences Ltd ranked by their cash flow conversion efficiency. Review BOLT financial flexibility index to assess the company's free cash flow relative to its total liabilities.

Company	Cash Flow Conversion Efficiency
Streamplay Studio Ltd AU:SP8	-0.037x
Exicure Inc NASDAQ:XCUR	-0.908x
Metal Bank Ltd AU:MBK	-0.024x
Ambertech Ltd AU:AMO	-0.183x
Bank Danamon Indonesia Tbk JK:BDMN	0.048x
Churchill Resources Inc V:CRI	-0.401x
Celsius Resources Limited F:FX8	-0.046x
Trellidor Holdings Ltd JSE:TRL	-0.060x

Annual Cash Flow Conversion Efficiency for BioLight Life Sciences Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of BioLight Life Sciences Ltd from 2012 to 2025. Also see total assets of BioLight Life Sciences Ltd for a full breakdown of the balance sheet.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	ILA40.17 Million ≈ $107.70K	ILA-10.85 Million ≈ $-29.10K	-0.270x	+24.45%
2024-12-31	ILA30.74 Million ≈ $82.42K	ILA-10.99 Million ≈ $-29.47K	-0.358x	-13.15%
2023-12-31	ILA30.30 Million ≈ $81.24K	ILA-9.58 Million ≈ $-25.68K	-0.316x	-77.88%
2022-12-31	ILA53.69 Million ≈ $143.95K	ILA-9.54 Million ≈ $-25.58K	-0.178x	-8.84%
2021-12-31	ILA61.42 Million ≈ $164.66K	ILA-10.03 Million ≈ $-26.88K	-0.163x	+13.89%
2020-12-31	ILA60.11 Million ≈ $161.14K	ILA-11.39 Million ≈ $-30.55K	-0.190x	+15.87%
2019-12-31	ILA68.15 Million ≈ $182.70K	ILA-15.36 Million ≈ $-41.17K	-0.225x	+21.70%
2018-12-31	ILA77.80 Million ≈ $208.57K	ILA-22.39 Million ≈ $-60.03K	-0.288x	+90.87%
2017-12-31	ILA8.03 Million ≈ $21.53K	ILA-25.32 Million ≈ $-67.88K	-3.153x	-92.02%
2016-12-31	ILA16.41 Million ≈ $43.99K	ILA-26.94 Million ≈ $-72.23K	-1.642x	-221.44%
2015-12-31	ILA47.06 Million ≈ $126.17K	ILA-24.04 Million ≈ $-64.44K	-0.511x	+51.29%
2014-12-31	ILA25.74 Million ≈ $69.00K	ILA-26.99 Million ≈ $-72.35K	-1.049x	+11.60%
2013-12-31	ILA22.11 Million ≈ $59.27K	ILA-26.23 Million ≈ $-70.31K	-1.186x	-127.59%
2012-12-31	ILA37.34 Million ≈ $100.10K	ILA-19.46 Million ≈ $-52.17K	-0.521x	--

About BioLight Life Sciences Ltd

TA:BOLT Israel Biotechnology

Market Cap

$6.54 Million

ILA2.44 Billion ILA

Market Cap Rank

#28133 Global

#402 in Israel

Share Price

ILA269.50

Change (1 day)

+0.56%

52-Week Range

ILA217.90 - ILA438.50

All Time High

ILA3485.66